Cano Health (CANO) Guidance Calls for 30% Growth at Analyst Day - Credit Suisse
Tweet Send to a Friend
Credit Suisse analyst A.J. Rice reiterated an Outperform rating and $10.00 price target on Cano Health (NYSE: CANO) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
